Benign multiple sclerosis? Clinical course, long term follow up, and assessment of prognostic factors

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Journal of Neurology Neurosurgery & Psychiatry

• Publication date

  1999-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1136/jnnp.67.2.148PMID 10406979PMCID PMC1736487
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Clinical parameters and intrathecal IgG synthesis as prognostic features in multiple sclerosis. Part I

  2004cited by this paper
• An epidemiologic study of multiple sclerosis in Northern Ireland.

  1999cited by this paper
• Estriol ameliorates autoimmune demyelinating disease

  1999cited by this paper
• The natural history of multiple sclerosis: a geographically based study. 5. The clinical features and natural history of primary progressive multiple sclerosis.

  1999cited by this paper
• Estrogen actions in the central nervous system.

  1999cited by this paper
• The prognostic value of brain MRI in clinically isolated syndromes of the CNS. A 10-year follow-up.

  1998cited by this paper
• Axonal damage correlates with disability in patients with relapsing-remitting multiple sclerosis. Results of a longitudinal magnetic resonance spectroscopy study.

  1998cited by this paper
• Rate of Pregnancy-Related Relapse in Multiple Sclerosis

  1998cited by this paper
• Axon loss in multiple sclerosis.

  1998cited by this paper
• Defining the clinical course of multiple sclerosis

  1996cited by this paper
• Prognostic factors in a multiple sclerosis incidence cohort with twenty-five years of follow-up.

  1993cited by this paper
• A population‐based study of multiple sclerosis in twins: Update

  1993cited by this paper
• A population-based study of multiple sclerosis in twins: update.

  1993cited by this paper
• The natural history of multiple sclerosis: a geographically based study. 3. Multivariate analysis of predictive factors and models of outcome.

  1991cited by this paper
• Disability due to multiple sclerosis: a community-based study on an Irish county.

  1986cited by this paper
• Presenting signs and symptoms in multiple sclerosis

  1986cited by this paper
• A clinical and laboratory study of benign multiple sclerosis.

  1986cited by this paper
• Onset symptoms as predictors of mortality and disability in multiple sclerosis

  1984cited by this paper
• Unsuspected multiple sclerosis.

  1983cited by this paper
• Multiple sclerosis. The spectrum of severity.

  1983cited by this paper
• New diagnostic criteria for multiple sclerosis: Guidelines for research protocols

  1983cited by this paper
• Factors associated with a rapid course of multiple sclerosis.

  1982cited by this paper
• Course of multiple sclerosis. First results of a prospective study carried out of 102 MS patients from 1976-1980.

  1982cited by this paper
• Course of multiple sclerosis

  1982cited by this paper
• Prognosis of multiple sclerosis *

  1982cited by this paper
• Prognosis of multiple sclerosis. Results from an epidemiological area in Germany.

  1982cited by this paper
• THE SOCIO‐ECONOMIC SCALE

  1981cited by this paper
• A PROPOSAL FOR A UNIFORM MINIMAL RECORD OF DISABILITY IN MULTIPLE SCLEROSIS

  1981cited by this paper
• Course and prognosis of multiple sclerosis assessed by the computerized data processing of 349 patients.

  1980cited by this paper
• Clinical data and the identification of special forms of multiple sclerosis in 1271 cases studied with a standardized documentation system.

  1979cited by this paper
• THE BENIGN FORM OF MULTIPLE SCLEROSIS

  1977cited by this paper
• Studies on the natural history of multiple sclerosis--8. Early prognostic features of the later course of the illness.

  1977cited by this paper
• [The course of multiple sclerosis. Study of 203 cases followed up for more than 10 years].

  1971cited by this paper
• MYELIN CONSTITUENTS OF HUMAN CENTRAL NERVOUS SYSTEM

  1970cited by this paper
• The course of multiple sclerosis in 73 cases with computer-designed curves.

  1970cited by this paper
• CLINICAL FACTORS ASSOCIATED WITH INCREASED DISABILITY IN MULTIPLE SCLEROSIS

  1970cited by this paper
• PSYCHOSES FOLLOWING WAR BRAIN INJURIES

  1969cited by this paper
• PROTEIN STUDIES ON CEREBROSPINAL FLUID AND NEUROLOGICAL SYMPTOMS IN MYELOMATOSIS

  1969cited by this paper
• Studies on epidemiological, clinical and etiological aspects of multiple sclerosis.

  1969cited by this paper
• PROGNOSTIC CRITERIA IN MULTIPLE SCLEROSIS

  1965cited by this paper
• The Benign form of Multiple Sclerosis: Results of a Long-term Study

  1964cited by this paper
• Clinical Features

  1963cited by this paper
• The benign form of multiple sclerosis. A study based on 241 cases seen within three years of onset and followed up until the tenth year or more of the disease.

  1961cited by this paper
• Some aspects of the natural history of disseminated sclerosis.

  1952cited by this paper
• of Prognostic Value of

  year unknowncited by this paper

• Benign multiple sclerosis and long-term outcomes after 30 years

  2025influential citation
• Navigating Multiple Sclerosis: From Clinical Categories to Clinical Management

  2025cites this paper
• Lifestyle factors associated with benign multiple sclerosis

  2025cites this paper
• Validation of the Patient-Determined Disease Steps in ambulatory older adults with multiple sclerosis.

  2025cites this paper
• Sex-chromosome complement and Activin-A shape the therapeutic potential of TNFR2 activation in a model of MS and CNP

  2025cites this paper
• Omega‐3 Fatty Acids Supplementation and Neuroprotection, Inflammation, Fatigue, and Physical Activity in Multiple Sclerosis: A Randomized Controlled Trial

  2025cites this paper
• Disability Worsening Phenotypes in Multiple Sclerosis and Impact of Disease-Modifying Treatments

  2025cites this paper
• Deciphering the shift from benign to active relapsing-remitting multiple sclerosis: Insights into T regulatory cell dysfunction and apoptosis regulation.

  2024influential citation
• Long-Term Disability Outcomes in Relapsing–Remitting Multiple Sclerosis Patients: Impact of Clinical and Demographic Factors on Disease Progression

  2024cites this paper
• Early clinical predictors of long-term disability progression in patients with multiple sclerosis

  2024cites this paper
• Identification of commensal gut microbiota signatures as predictors of clinical severity and disease progression in multiple sclerosis

  2024cites this paper
• Longitudinal Optical Coherence Tomography Measurement of Retinal Ganglion Cell and Nerve Fiber Layer to Assess Benign Course in Multiple Sclerosis

  2023cites this paper
• Identification of commensal gut microbiota signatures as predictors of clinical severity and disease progression in multiple sclerosis

  2023cites this paper
• MS becomes a treatable disease: 30 years later

  2023cites this paper
• Alemtuzumab for multiple sclerosis.

  2023cites this paper
• Potential biological contributers to the sex difference in multiple sclerosis progression

  2023cites this paper
• The influence of fatigue on the daily functioning of multiple sclerosis patients

  2023cites this paper
• Changes in prognosis of the Danish multiple sclerosis population over time

  2022cites this paper
• β-Adrenoceptor Blockade Moderates Neuroinflammation in Male and Female EAE Rats and Abrogates Sexual Dimorphisms in the Major Neuroinflammatory Pathways by Being More Efficient in Males

  2022cites this paper
• Progression of Relapsing-Remitting Multiple Sclerosis despite the new era of treatments

  2022cites this paper
• Magnetic Resonance Imaging as a Prognostic Disability Marker in Clinically Isolated Syndrome and Multiple Sclerosis: A Systematic Review and Meta-Analysis

  2022cites this paper
• Truth Be Damned

  2021cites this paper
• HLA genotype-clinical phenotype correlations in multiple sclerosis and neuromyelitis optica spectrum disorders based on Japan MS/NMOSD Biobank data

  2021cites this paper
• MRI but not demographic or clinical characteristics differ between familial and sporadic MS cases.

  2021cites this paper
• HLA genotype-clinical phenotype correlations in multiple sclerosis and neuromyelitis optica spectrum disorders based on Japan MS/NMOSD Biobank data

  2021cites this paper
• Is the incidence of multiple sclerosis really increasing?

  2020cites this paper
• Expression Levels of Inflammasome Complexes in Experimental Autoimmune Myasthenia Gravis Mouse Model (EAMG)

  2020cites this paper
• B Cell Immunophenotyping and Expression Analysis of B Cell Specific Molecules of Patients with Benign Multiple Sclerosis

  2020cites this paper
• The TOTEM RRMS (Testosterone Treatment on neuroprotection and Myelin Repair in Relapsing Remitting Multiple Sclerosis) trial: study protocol for a randomized, double-blind, placebo-controlled trial

  2020cites this paper
• Sex differences in steroid levels and steroidogenesis in the nervous system: physiopathological role.

  2020cites this paper
• Prediction of disease progression and outcomes in multiple sclerosis with machine learning

  2020cites this paper
• Structural connectivity in multiple sclerosis and modeling of disconnection

  2019cites this paper
• Autoimmune Disease in Women: Endocrine Transition and Risk Across the Lifespan

  2019cites this paper
• Health care services and disease modifying therapies use in community-based multiple sclerosis patients: Evolution from 2013 to 2015 and demographic characteristics.

  2019cites this paper
• A 30‐Year Clinical and Magnetic Resonance Imaging Observational Study of Multiple Sclerosis and Clinically Isolated Syndromes

  2019cites this paper
• Association of circulating anti-CD64 IgM levels with favourable long-term clinical outcomes in multiple sclerosis patients.

  2019cites this paper
• Cognitive function in multiple sclerosis: A long-term look on the bright side

  2019cites this paper
• Factors associated with and long-term outcome of benign multiple sclerosis: a nationwide cohort study

  2019cites this paper
• How common is truly benign MS in a UK population?

  2018cites this paper
• Effects of computer-assisted cognitive rehabilitation in benign multiple sclerosis

  2018cites this paper
• Investigation of the adaptive immune response in multiple sclerosis

  2018influential citation
• MRI Markers and Functional Performance in Patients With CIS and MS: A Cross-Sectional Study

  2018cites this paper
• Testosterone and estrogen in multiple sclerosis: from pathophysiology to therapeutics

  2018cites this paper
• Natural history of benign multiple sclerosis: Clinical and HLA correlates in a Western Australian cohort.

  2018cites this paper
• Functional network connectivity abnormalities in multiple sclerosis: Correlations with disability and cognitive impairment

  2018cites this paper
• Magnetic resonance imaging of experimental autoimmune encephalomyelitis in the common marmoset.

  2017cites this paper
• MRI biomarkers in multiple sclerosis. Perfusion weighted imaging and restriction spectrum imaging

  2017cites this paper
• Endoplasmic reticulum stress signalling in myelination

  2017cites this paper
• Disease-modifying therapies can be safely discontinued in an individual with stable relapsing-remitting MS – NO

  2017cites this paper
• Definition, prevalence and predictive factors of benign multiple sclerosis

  2017cites this paper
• Magnetic resonance imaging perfusion is associated with disease severity and activity in multiple sclerosis

  2017cites this paper
• Testosterone Treatment in Multiple Sclerosis

  2017cites this paper
• 4.23 – Sex Differences in Autoimmune Diseases

  2017cites this paper
• Cerebellar contribution to motor and cognitive performance in multiple sclerosis: An MRI sub-regional volumetric analysis

  2017cites this paper
• Experimental Autoimmune Encephalomyelitis Ameliorated by Passive Transfer of Polymerase 1-Silenced MOG35-55 Lymphatic Node Cells: Verification of a Novel Therapeutic Approach in Multiple Sclerosis

  2017cites this paper
• RAM-589.555 a new Polymerase-1 inhibitor as innovative targeted-treatment for multiple sclerosis.

  2017cites this paper
• Benign multiple sclerosis: aspects of cognition and neuroimaging

  2016cites this paper
• Severity Grading in Multiple Sclerosis

  2016cites this paper
• Factors associated with benign multiple sclerosis in the New York State MS Consortium (NYSMSC)

  2016cites this paper
• Alemtuzumab for multiple sclerosis.

  2016cites this paper
• Levels and actions of neuroactive steroids in the nervous system under physiological and pathological conditions: Sex-specific features.

  2016cites this paper
• Abnormalities of the executive control network in multiple sclerosis phenotypes: An fMRI effective connectivity study

  2016influential citation
• The epidemiology of multiple sclerosis: insights to a causal cascade.

  2016cites this paper
• Multiple sclerosis.

  2016cites this paper
• Interleukin 7 receptor polymorphisms and the risk of multiple sclerosis: A meta-analysis.

  2016cites this paper
• >CME/CNE ARTICLE: Severity Grading in Multiple Sclerosis: A Proposal.

  2016cites this paper
• Multiple Sclerosis and Allied Demyelinating Diseases

  2016cites this paper
• The Role of Gender in Early Onset Relapsing Remitting Multiple Sclerosis

  2015cites this paper
• Systematic imaging review: Multiple Sclerosis

  2015cites this paper
• Male rats develop more severe experimental autoimmune encephalomyelitis than female rats: sexual dimorphism and diergism at the spinal cord level.

  2015cites this paper
• Prognostic Indicators in Patients with Relapsing Remitting Multiple Sclerosis

  2015cites this paper
• Eficacia de las terapias celular y génica como agentes inmunomoduladores en el tratamiento de la esclerosis múltiple

  2015cites this paper
• Investigating the role of Epstein-Barr virus in the pathogenesis of Multiple Sclerosis

  2015cites this paper
• Multiple sclerosis—a quiet revolution

  2015cites this paper
• Combined GSTP1 and NQO1 germline polymorphisms in the susceptibility to Multiple Sclerosis

  2015cites this paper
• Sex-Based Differences in Multiple Sclerosis (MS): Part II: Rising Incidence of Multiple Sclerosis in Women and the Vulnerability of Men to Progression of this Disease.

  2015cites this paper
• Impaired functional integration in multiple sclerosis: a graph theory study

  2014cites this paper
• Relationship between damage to the cerebellar peduncles and clinical disability in multiple sclerosis.

  2014cites this paper
• The Effect of an Aquatic Training Program on Walking Ability and Quality of Life of Patients with Multiple Sclerosis

  2014cites this paper
• The clinical course of multiple sclerosis.

  2014cites this paper
• Early prognosis of multiple sclerosis.

  2014cites this paper
• Toll‐like receptor‐9 in Spanish multiple sclerosis patients: an association with the gender

  2014cites this paper
• Usability and Potential of Geostatistics for Spatial Discrimination of Multiple Sclerosis Lesion Patterns

  2014cites this paper
• The epidemiology of multiple sclerosis: insights to disease pathogenesis.

  2014cites this paper
• Current and future potential of retinal optical coherence tomography in multiple sclerosis with and without optic neuritis.

  2014cites this paper
• Gender effects on treatment response to interferon‐beta in multiple sclerosis

  2014cites this paper
• Polymerase I pathway inhibitor ameliorates experimental autoimmune encephalomyelitis.

  2013cites this paper
• Self‐assessed health status changes in a community cohort of people with multiple sclerosis: 11 years of follow‐up

  2013cites this paper
• Subcutaneous Interferon β-1a May Protect against Cognitive Impairment in Patients with Relapsing–Remitting Multiple Sclerosis: 5-Year Follow-up of the COGIMUS Study

  2013cites this paper
• Wallerian and trans-synaptic degeneration contribute to optic radiation damage in multiple sclerosis: a diffusion tensor MRI study

  2013cites this paper
• Low degree of cortical pathology is associated with benign course of multiple sclerosis

  2013cites this paper
• UNIVERSITY OF NOVA GORICA GRADUATE SCHOOL GENETICS BIOMARKERS AT MULTIPLE SCLEROSIS DISSERTATION

  2013cites this paper
• Ein Paradigmenwechsel und die Zukunft

  2013cites this paper
• Immunosuppressive monoclonal antibody to CD64 from patients with long-term stable multiple sclerosis.

  2013cites this paper
• Polymerase I Pathway Inhibitor Ameliorates Experimental Autoimmune Encephalomyelis (P05.173)

  2013cites this paper
• ‘Clinically definite benign multiple sclerosis’, an unwarranted conceptual hodgepodge: evidence from a 30-year observational study

  2013cites this paper
• Evoluzione della malattia

  2013cites this paper
• Gray matter damage predicts the accumulation of disability 13 years later in MS

  2013cites this paper
• Risk-benefit considerations in the treatment of relapsing-remitting multiple sclerosis

  2013cites this paper
• The Impact of Osteopontin Gene Variations on Multiple Sclerosis Development and Progression

  2012influential citation